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Purpose: This study was designed to compare the clinicopathologic findings of an endoscopic polypectomy for malignant 
polyps with subsequent surgery and to evaluate the appropriateness of the pathologic finding criterion of the resection mar-
gin as an indicator for surgery in cases of malignant colorectal polyps.
Methods: We examined the clinicopathologic characteristics, complications and prognoses among the patients who under-
went a colonoscopic polypectomy in both our hospitals and at other hospitals from April 2003 and April 2010. These pa-
tients were divided into two groups, the group (non-operation group) that only underwent a polypectomy (n = 37) and 
the group (operation group) that underwent a polypectomy with subsequent surgery (n = 33).
Results: There were no differences between two groups in the ratios of the number of men to the number of women, the 
ages or the comorbidities. In terms of endoscopic findings, we found no differences between the two groups in the loca-
tions of the polyps, the sizes of the polyps, or the presence of stalks. However, ulceration of polyps was higher in the non-
operation group (51.5% vs. 21.6%; P = 0.009), as was the case with submucosal invasion (75.8% vs. 16.2%; P < 0.005). When 
an endoscopic polypectomy was performed, incomplete resection margins and specimens with margins involved occurred 
more frequently in the operation group (93.9% vs. 51.4%; P < 0.005), but no residual tumor was detected in 31 of 33 (93.9%) 
patients in that group. One pathologist reviewed the specimens of 54 patients (operation group, 19; non-operation group, 
36). Six of the 19 polyps (31.6%) in the operation group and fifteen of the 36 polyps (41.7%) in the non-operation group 
had a margin without cancer cells.
Conclusion: We may accept the criterion of a safe margin, including a coagulation zone. A multidisciplinary approach has 
to be developed by surgeons, endoscopists and pathologists based on a discussion of the risk factors for the patient before 
making a decision on the treatment treatment.
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of all polyps that are endoscopically removed (mean, 4.7%) [2] and 
9-11% of all polyps that are surgically removed [3]. In past years 
when endoscopy and endoscopic treatment were at their initial 
stages, malignant polyps were mainly removed by surgical treat-
ment. Therefore, the diagnosis and the infiltration of the malignant 
polyp were accurately identified. As endoscopic resections of ma-
lignant polyps have been conducted since 1970, the uncertainty   
in the diagnosis and in the treatment of malignant polyps has in-
creased due to uncertain information on the endoscopically-re-
sected tissues. Conventionally, in the case of adenomas restricted 
intramucosally with no lymphovascular metastasis, a successful 
treatment was expected when using an endoscopic was resection. 
On the contrary, in the case of submucosal invasion, the Ameri-
can Joint Committee on Cancer (AJCC) recommended surgical 
treatment in cases involving poor histological differentiation, un-
INTRODUCTION
In general, an adenomatous polyp in which cancer cells occur in 
intramucosal or submucosal lesions is called a malignant polyp [1]. 
Such malignant polyps have been reported to account for 2.6-9.7% 
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clear resection margin, and lymphovascular metastasis [4]. How-
ever, after the surgery recommended by AJCC, clinical cases with 
no residual tumor were sometimes observed using histologic ex-
amination. This result raises the question of whether the appro-
priate treatment method had been applied. Accordingly, in order 
to investigate factors in tissues resected before surgery that affect 
surgical treatment, we conducted this study on patients who were 
suspected of having a malignant polyp on histologic examination 
after a colonoscopic polypectomy and who subsequently under-
went surgical treatment, but who had no residual cancer in the final 
histologic examination after the surgery.
METHODS
This study was conducted on 70 patients who had undergone an 
endoscopic polypectomy for malignant polyps at the authors’ hos-
pital and at other hospitals from April 2003 to April 2010. After 
the polypectomy, the patients were divided into the surgery group 
and the non-surgery group, and their clinical and pathological char-
acteristics, complications and prognoses were retrospectively in-
vestigated. Patients with malignant polyps in the rectum to which 
a full-thickness resection could be applied, such as transanal exci-
sion, with rectal cancer, with anal cancer treated with chemother-
apy before surgery, and with genetic diseases, such as familial ade-
nomatous polyposis, were excluded.
Endoscopic resection included a plain polypectomy, an endo-
scopic mucosal resection in which the submucosal layer is treated 
with 0.9% saline-epinephrineby using a 23-gauge needle to elevate 
lesions and the mucosal layer is then en-bloc resected using a loop 
snare, and an endoscopic submucosal dissection using an electro-
cautery knife. A laparotomy or a laparoscopic colorectal resection 
was conducted as a surgical treatment. Pathological examinations 
were conducted on tissue samples endoscopically resected to inves-
tigate tumor size, resection margin status, histological type and dif-
ferentiation, invasion depth, and lymphovascular invasion. For en-
doscopic dissection of the submucosal layer, the resection margin 
was clearly identified. Meanwhile, depending on the tissue samples, 
for mucosal resection, some cases in which the resection margin 
had not been identified were included. The invasion depth was 
divided into the mucosal and the submucosal layers. A free mar-
gin of 2 mm or more in the resection margin was included in the 
criterion for a complete resection, but the area coagulated by elec-
trocautery was not included.
The resection margin status was defined as a complete resection 
when the free margin ≥ 2 mm, as an incomplete resection when   
1 mm ≤ free margin < 2 mm, as positive when cancer was present 
in the resection margin or when the free margin was less than 1 mm, 
and as uncertain when the accuracy of the resection margin was 
uncertain due to piecemeal resection. In addition, the surgery cri-
teria of the authors’ hospital included residual cancer in the resec-
tion margin, incomplete securing of the resection margin, poor 
histologic differentiation, and lymphovascular metastasis in the 
tissue samples.
The pathologic reexaminations of the tissue samples were con-
ducted by one pathologist. In particular, samples from the initial 
endoscopic polypectomies, which had been obtained from patients 
who had been reported to have no residual cancer after surgery, 
were carefully reexamined. At that time, the distance to the resec-
tion margin, including the coagulated area, was measured again.
For observation of the outcome observation, abdominal com-
puted tomography (CT) was conducted to identify lymphatic me-
tastasis before and after the endoscopic polypectomy, or before and 
after surgery. An endoscopic examinations were conducted on pa-
tients who had undergone endoscopic polypectomies without sur-
gical treatment to follow-up on the lesion and were performed 2 
weeks after the treatment, which was the earliest examination; this 
was generally followed by colonoscopy at 2-8 weeks, 4-6 months, 
and 2-3 years after the treatment. The mean follow-up period was 
24 months.
A statistical analysis was conducted using SPSS ver. 14.0 (SPSS 
Inc., Chicago, IL, USA). Chi-square and Independent t-tests were 
performed, depending on the characteristics of the variables, to 
test statistical significance. P-values < 0.05 were considered statis-
tically significant.
RESULTS
For a comparative analysis, a total of 70 patients was divided into 
two groups: 37 patients (non-surgery group) who had undergone 
an endoscopic polypectomy and 33 patients (surgery group) who 
had undergone surgical treatment after a polypectomy. No signifi-
cant differences in general characteristics, such as gender, age, and 
concurrent diseases, were found between the two groups (Table 1).
In the comparison of gross findings on the characteristics of the 
polyp, no differences in polyp location, size and stalk were found, 
but more surface ulceration was shown in the surgery group (21.6% 
Table 1. Characteristics of the patients
Non-operation 
group (n = 37)




   Male 25 (67.6) 23 (69.7)
   Female 12 (32.4) 10 (30.3)
Age (yr) NS
   <60 12 (32.4) 15 (45.5)
   ≥60 25 (67.6) 18 (54.5)
Comorbidity NS
   No 30 (81.1) 23 (69.7)
   Yes   7 (18.9) 10 (30.3)
Values are presented as number (%).
Comorbidity is disease of two or more organs, such as the heart, lung, kidney or 
endocrine organ.Journal of The Korean Society of
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vs. 51.5%; P = 0.009). In the comparison of pathologic findings, 
well or moderate differentiation was shown in both groups, and 
submucosal invasion was shown more in the surgery group than 
in the non-surgery group (16.2% vs. 75.8%; P < 0.005) (Table2). 
For resection margin status, an incomplete resection was shown 
more in the surgery group than in the non-surgery group accord-
ing to the histologic findings at the time of treatment (37.8% vs. 
84.8%). Based on the aforementioned, the results for the resection 
margin, which significantly affected surgical treatment, were ana-
lyzed in detail.
Among the patients who had not undergone surgical treatment, 
the resection margin was shown to be positive in 6 patients of 22 
patients with incomplete securing of the resection margin or with 
a positive or an uncertain resection margin. Histologic reexamina-
tion after endoscopic follow-up was conducted to determine the 
conduct of surgical treatment in these six patients due to a brain 
lesion in one patient, an intramucosal lesion in three patients, a 
personal reason in one patient, and old age in one patient. How-
ever, no additional surgical treatment was conducted on these six 
patients as no cancer was found on the histologic reexamination. 
In cases of incomplete resection and uncertain resection margin, 
no surgical treatment was conducted as an intramucosal lesion 
was shown in most cases. An incomplete resection was shown in 
one patient with submucosal invasion, and surgical treatment was 
recommended. Endoscopic histologic examination was conducted 
under the patient’s permission as good differentiation of the lesion 
and no lymphovascular metastasis were shown. As no residual can-
cer was found, no surgical treatment was conducted. Endoscopic 
histologic examinations were conducted on the remaining patients 
as intramucosal lesions were shown in all of them. The result of the 
examination also showed no residual cancer.
Among the surgery group, an endoscopic complete resection was 
performed in two patients, one who showed an intramucosal le-
sion and one who showed a submucosal lesion. However, these 
two patients still desired surgical treatment. Among the remain-
ing 31 patients, surgical treatment was conducted on 15 patients 
due to an uncertain resection margin, 7 patients due to an incom-
plete resection, and 9 patients due to a positive resection margin. 
Lymphatic metastasis on abdominal CT was suspected in one pa-
tient who showed submucosal invasion and a positive resection 
margin. Among the 33 patient who had undergone surgical treat-
ment, no residual cancer was observed in 31 patients (93.9%) as a 
result of the final histologic examination. An incomplete resection 
Table 2. Clinicopathologic characteristics of polyps
Non-operation 
group (n = 37)
Operation group 
B (n = 33)
P-value
Location NS
   Right colon       8 (21.6)      4 (12.1)
   Left colon    19 (51.4)    17 (51.5)
   Rectum    10 (45.5)    12 (36.4)
Size (mm) NS
   0-9      9 (24.3)      4 (12.1)
   10-19    23 (62.2)    23 (69.7)
   20-29      4 (10.8)      5 (15.2)
   30-39    1 (2.7)    1 (3.0)
Stalk NS
   No    25 (67.6)    21 (63.6)
   Yes    12 (32.4)    12 (36.4)
Ulcer 0.009
   No    29 (78.4)    16 (48.5)
   Yes      8 (21.6)    17 (51.5)
Differentiation NS
   Well    20 (54.1)      6 (18.2)
   Moderate    17 (45.9)    27 (81.8)
Poor or signet ring cell    0 (0.0)    0 (0.0)
Margin 0.001
   Complete
a    15 (40.5)    2 (6.1)
   Incomplete
b      7 (21.6)    3 (9.1)
   Positive
c    6 (8.1)      9 (27.3)
   Undetermined      9 (29.7)    19 (57.6)
Depth of Invasion <0.005
   Mucosa    31 (83.8)      8 (24.2)
   Submucosa      6 (16.2)    25 (75.8)
CT nodal state NS
   Absent   37 (100) 32 (97)
   Present 0 (0) 1 (3)
Values are presented as number (%).
a≥2 mm. 
b1 mm ≤ but < 2 mm. 
c<1 mm.
Table 3. Characteristics of resection margin on the review slide
Non-operation group  
(n = 36)
Operation group  
(n = 19)
Complete 15 6
   Mucosa 13 2
   Submucosa   2 4
Incomplete   8 6
   Mucosa   7 1
   Submucosa   1 5
Undetermined 10 7
   Mucosa 10 5
   Submucosa - 2
Positive   3 -
   Mucosa -
   Submucosa   3Journal of The Korean Society of
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and an uncertain resection margin, respectively, was observed in 
two patients who showed residual cancer. The pathologic findings 
of the initial polypectomies in the surgery group were reexamined 
by one pathologist, and at that time, the distance between the tumor 
and the resection margin, including the coagulated area, was mea-
sured. The numbers of samples tested before surgery were shown 
to be 19 in the surgery group and 36 in the non-surgery group. Ac-
cording to the results of the sample testing, complete resections 
were shown in 6 of 19 patients (31.6%) in the surgery group and 
in 15 of 36 patients (41.7%) in the non-surgery group. An incom-
plete resection with 1 mm ≤ resection margin < 2 mm was shown 
in 6 of 19 patients (31.6%) in the surgery group and in 8 of 36 pa-
tients (22.2%) in the non-surgery group (Table 3, Figs. 1-2). Among 
the 13 patients who had shown a complete resection of an intramu-
cosal lesion in the non-surgery group, an incomplete resection and 
an uncertain resection margin were shown in one patient. Among 
the four patients who had shown an incomplete resection, a com-
plete resection was shown in one patient. Both patients who had 
shown a positive resection margin in the non-surgery group showed 
an incomplete resection. Among the 11 patients who had shown 
an uncertain resection margin, a complete resection was shown 
in one patient.
The results of histologic reexaminations of the samples from the 
patients who had shown submucosal lesions in the non-surgery 
group before and after reexamination were consistent. Further-
more, as a result of the histologic reexaminations of the intramu-
cosal lesions in the surgery group, a complete resection was shown 
in one patient who had shown a positive resection margin. As a 
Polypectomy group  
(n = 37)  36
Mucosal invasion  
(n = 31)  30
Complete  













(n = 3)  0
Positive  
(n = 3)
Undetermined   
(n = 11)  10
Undetermined   
(n = 0)
Submucosal invasion  
(n = 6)  6
Fig. 1. Result of margin in polypectomy group. Red color letter means result of review margin.
Operative group  
(n = 33)  19
Mucosal invasion  
(n = 8)  7
Complete  
(n = 1)  2
Complete  
(n = 1)  4
Incomplete  
(n = 1)  1
Incomplete  
(n = 6)  5
Positive  
(n = 1)  0
Positive  
(n = 8)  0
Undetermined  
(n = 5)  5
Surgery
Undetermined  
(n = 10)  2
Submucosal invasion  
(n = 25)  12
Fig. 2. Result of margin in operation group. Red color letter menas result of review margin.Journal of The Korean Society of
Coloproctology
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result of histologic reexaminations of the submucosal lesions in 
the surgery group, one of two patients who had shown an incom-
plete resection showed a complete resection, all four patients who 
had shown a positive resection margin showed an incomplete re-
section, and three of five patients who had shown an uncertain 
resection showed a complete resection. The aforementioned re-
sults were inconsistent with those of the preliminary examination 
(Fig. 3).
Identifying the exact presence of lymphovascular invasion in the 
tissue samples from patients who had undergone a polypectomy 
due to cutting problems in the preparation of tissue samples in the 
cases of the partial removal of the tissue or removal by piecemeal 
resection was difficult. Accordingly, the results of analyzing lym-
phovascular invasion were excluded from this study as no statisti-
cal significance was found due to the small number of the patients 
who showed significant results.
During the follow-up, one patient in the surgery group under-
went anticancer therapy due to recurrence caused by lung metas-
tasis. A complete resection was shown in this patient, who had 
shown a submucosal lesion on the histologic examination before 
surgery and no lymphatic metastasis. Meanwhile, no recurrence 
was found in the non-surgery group. No cancer-related death was 
found in either group. One patient in the surgery group died of 
pneumonia, independently of the surgery, during the follow-up 
period. No recurrence was found in the remaining 34 patients, 
but three patients in the non-surgery group were lost during the 
follow-up period. The mean follow-up period was 245 months 
(range, 0.9 to 69.1 months)
DISCUSSION
Most colorectal cancer has been reported to start as an adenoma 
and to occur via the adenoma-carcinoma sequence. Accordingly, 
studies on endoscopic resections of adenomas have been actively 
conducted [5]. Morson et al. [6] and Hermanek et al. [7] classified 
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Fig. 3. Compared figure with excepted vs. included coagulation zone.Journal of The Korean Society of
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polyp size, histologic finding, stalk invasion, depth of tumor inva-
sion, growth of sessile polyp, and vascular and lymphatic invasion. 
They reported that malignant polyps could be effectively treated 
by using a complete local resection in the patients who had well-
differentiated or moderately differentiated adenocarcinomas with 
no vascular and lymphatic invasion and who under regular endo-
scopic follow-ups. However, the aforementioned criteria could 
only be applied in cases of complete resection into a single piece. 
For piecemeal resection, surgical treatment should be considered 
due to low pathohistological accuracy [8].
More unfavorable histologic findings have been reported in ses-
sile polyps. Nevertheless, many studies reported that an endoscopic 
polypectomy alone was sufficient to treat sessile polyps, regardless 
of polyp type, in low-risk groups that showed no malignant resec-
tion margin, good differentiation and no lymphovascular invasion 
[9]. As shown in this study, in the endoscopic examination, no dif-
ference in the prevalences of pedunculated polyps and sessile pol-
yps was found between the two groups. However, in the case of 
ulceration on the polyp surface, surgical treatment was more pre-
ferred, which indicated a closer relationship with the degree of ma-
lignancy [10, 11].
For polyp removal, pedunculated polyps can be easily removed 
using a loop snare whereas sessile polyps or flat lesions are more 
likely to be removed via a piecemeal resection. In this case, despite 
the high possibility of a residual tumor or flat lesion cells in the re-
section margin, approximately 1/3 of malignant polyps are treated 
via piecemeal resection [11, 12]. Considering that en-bloc resection 
can be available in the case of endoscopic dissection of the submu-
cosal layer and that an 84.9% form preservation and a 75.3% ver-
tical and external free margin can be obtained [13], submucosal 
dissection should be considered as an appropriate method of re-
moval for malignant polyps. That study [13] also showed that the 
number of patients who could be treated via endoscopic resection 
alone had increased since 2007 as a sufficient resection margin was 
secured due to increased numbers of endoscopic mucosal resec-
tions and endoscopic submucosal dissections.
The pathohistologic findings on the free resection margin showed 
that recurrence was 0-2% when the free margin ≥ 1 mm and 21-
33% when either the free margin < 1 mm or a residual tumor was 
present in the resection margin [14]. In general, recurrence has 
been believed to be unlikely for a safe resection margin of ≥ 2 mm. 
However, considering tissues destroyed by diathermy, the criteria 
of resection margin size and no residual tumor in the resection 
margin remain to be investigated [10]. In this study, the resection 
margins, including the coagulated areas after polypectomy, were 
reexamined by one pathologist. Compared to the initial findings, 
the result of reexamination showed an increased number of com-
plete resections and a decreased number of resection margin inva-
sions. This result is likely associated with the inclusion of the co-
agulated area (Figs. 1, 2). Based on this result, measurement of the 
safe free margin, including the coagulated area, should be consid-
ered.
Muller et al. reported that intrasubmucosal vascular or lymphatic 
metastasis was observed in 17.6% of patients after a polypectomy, 
of whom 83.3% showed local lymph node metastasis or local re-
currence [15]. However, most studies reported that vascular inva-
sion was not recognized as an independent high-risk factors [9, 
15], and many researchers, except for Cooper et al. [14], suggested 
that lymphatic invasion could be considered as a high-risk factor 
[9]. In fact, determining actual lymphatic invasion is difficult due 
to the retraction artifact of the resection margin caused by the re-
section itself [14, 16].
Although the reexaminations were performed by one patholo-
gist in this study, conclusive results were not obtained due to the 
small number of samples clearly showing lymphovascular inva-
sion. Nivatvongs et al. conducted a study targeting 151 patients 
who had had malignant polyps removed via surgical treatment. 
They reported that the subjects who had both lymphovascular me-
tastasis and lymph node metastasis accounted for 31% of the pa-
tients [17] and that no patient with intramyomucosal peduncu-
lated polyps showed lymphovascular metastasis, but the impor-
tance of lymphovascular metastasis significantly increased in cases 
of submucosal invasion. The aforementioned results are consistent 
with those of some other studies reporting a positive relationship 
between sessile polyps and the risk of lymph node metastasis [18-
20]. However, in this study, no recurrence was found in the case 
of sessile polyps that had shown favorable histologic results dur-
ing the mean follow-up period.
Malignant polyps are divided into three grades, well, moderate 
and poor differentiation, according to tissue differentiation. Polyps 
with poor differentiation are not easily observed. Hassan et al. [18] 
reported that polyps with poor differentiation were observed in 
7.2% of malignant polyps. No polyps with poor differentiation were 
found in this study. Despite this result, the reason that differentia-
tion plays an important role in the determination of the treatment 
method of malignant polyps is the fact that more harmful results 
are believed to occur in tissues with poor differentiation [2, 6, 14, 
21]. Coverlizza et al. [2] reported that poor differentiation was a 
very important risk factor as 50% of lesions with poor differentia-
tion showed lymph node metastasis and that signet ring cell type 
was considered to be the same as poor differentiation.
If a malignant polyp is identified, either follow-up after endoscopic 
polypectomy or surgical treatment should be determined by con-
sidering the aforementioned risk factors. Colacchio et al. [22] con-
ducted a study on 39 patients diagnosed with malignant polyps. 
They reported that a polypectomy alone was conducted on 15 pa-
tients who had refused surgical treatment and that lymphatic me-
tastasis was found in 25% of the 24 patients who had undergone 
surgical treatment. They reported that prediction before surgery 
was impossible, that all patients diagnosed with malignant polyps 
should be considered high-risk, and that surgical treatment should 
be conducted on them. However, they acknowledged the selection 
bias of their study and suggested that the treatment method for 
malignant polyps could change [23]. On the other hand, Chapman Journal of The Korean Society of
Coloproctology
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et al. [24] reported that polyps completely resected by experienced 
endoscopists could be treated via endoscopic resection regardless 
of risk factors. The result of a study, which was recently conducted 
by Seit et al. [21] on 114 patients who had undergone an endo-
scopic polypectomy of a malignant polyp, showed that poor out-
comes were obtained from 60 high-risk patients due to the rele-
vant malignant tumor whereas good outcomes were obtained from 
54 low-risk patients regardless of the tumor. They suggested that a 
more active treatment should be conducted if risk factors are iden-
tified during the pathohistologic examination [21, 25]. In this study, 
surgery was performed on the patients that were considered to have 
risk factors on the histologic examination after the polypectomy. 
However, on the final histologic examination, no residual cancer 
was found in 31 (93.9%) of the 33 patients. Furthermore, good treat-
ment outcomes without recurrence during the follow-up period 
were obtained from patients who had been considered to have risk 
factors after the polypectomy, but who had undergone follow-up 
according to their wishes or the endoscopist’s judgment. Consid-
ering the aforementioned results, each patient’s characteristics, his-
tologic findings, risk of residual cancer, and risk of surgical treat-
ment should be considered together in the selection of a treatment 
method appropriate for that patient.
For mucosal cancer, the treatment outcome can be followed-up 
via secondary endoscopic resection even though a complete re-
section is not obtained. Meanwhile, for submucosal cancer, the 
treatment method should be determined by considering various 
risk factors in the case of incomplete resection. In addition, for se-
curing the resection margin, a result including the coagulated area 
is likely to be effective. In summary, if an appropriate treatment 
method for a malignant polyp is to be selected, a multidisciplinary 
approach to the risk factors of each patient among surgeons, en-
doscopists, and pathologists is recommended.
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